Top

Published in:

01-12-2009 | Commentary

Host immune response in sepsis due to ventilator-associated pneumonia: how is it different?

Author: Eirini Christaki

Published in: Critical Care | Issue 6/2009

Abstract

Current evidence regarding potentially different host response mechanisms in sepsis according to the type of initiating infection is sporadic. It is possible that alterations in cell populations, variations in effector molecules, and the degree of apoptosis differ between sepsis caused by ventilator-associated pneumonia (VAP) and non-VAP sepsis. VAP is one of the most common infections and leading causes of sepsis in the intensive care unit, and mortality remains high. A better understanding of the unique pathophysiologic features of VAP is needed in order to develop interventions that target those specific pathways.

Pelekanou A, Tsagkaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ: Decrease of CD4 lymphocytes and apoptosis of CD14 monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care 2009, 13: R172. 10.1186/cc8148PubMedCentralCrossRefPubMed

Williams MA, Withington S, Newland AC, Kelsey SM: Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo . J Infect Dis 1998, 178: 1421-1433. 10.1086/314447CrossRefPubMed

Giamarellos-Bourboulis EJ, Routsi C, Plachouras D, Markaki V, Raftogiannis M, Zervakis D, Koussoulas V, Orfanos S, Kotanidou A, Armaganidis A, Roussos C, Giamarellou H: Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Crit Care 2006, 10: R76. 10.1186/cc4921PubMedCentralCrossRefPubMed

Cavaillon JM, Adib-Conquy M: Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006, 10: 233. 10.1186/cc5055PubMedCentralCrossRefPubMed

Biswas SK, López-Collazo E: Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30: 475-487. 10.1016/j.it.2009.07.009CrossRefPubMed

del Fresno C, Soler-Rangel L, Soares-Schanoski A, Gómez-Piña V, González-León MC, Gómez-García L, Mendoza-Barberá E, Rodríguez-Rojas A, García F, Fuentes-Prior P, Arnalich F, López-Collazo E: Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. J Endotoxin Res 2007, 13: 39-52. 10.1177/0968051907078623CrossRefPubMed

del Fresno C, Gómez-Piña V, Lores V, Soares-Schanoski A, Fernández-Ruiz I, Rojo B, Alvarez-Sala R, Caballero-Garrido E, García F, Veliz T, Arnalich F, Fuentes-Prior P, García-Río F, López-Collazo E: Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS One 2008, 3: e2667. 10.1371/journal.pone.0002667PubMedCentralCrossRefPubMed

Safdar N, Crnich CJ, Maki DG: The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005, 50: 725-739. discussion 39-41PubMed

Murphey ED, Fang G, Sherwood ER: Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus . Shock 2008, 29: 512-518. 10.1097/SHK.0b013e318150776fPubMed

10.

Murphey ED, Fang G, Varma TK, Sherwood ER: Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma. Shock 2007, 27: 289-295. 10.1097/01.shk.0000245024.93740.28CrossRefPubMed

11.

Wheeler DS, Lahni PM, Denenberg AG, Poynter SE, Wong HR, Cook JA, Zingarelli B: Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 2008, 30: 267-273. 10.1097/SHK.0b013e318162c190PubMedCentralPubMed

12.

del Fresno C, García-Rio F, Gómez-Piña V, Soares-Schanoski A, Fernández-Ruíz I, Jurado T, Kajiji T, Shu C, Marín E, Gutierrez del Arroyo A, Prados C, Arnalich F, Fuentes-Prior P, Biswas SK, López-Collazo E: Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009, 182: 6494-6507. 10.4049/jimmunol.0803350CrossRefPubMed

Title: Host immune response in sepsis due to ventilator-associated pneumonia: how is it different?
Author: Eirini Christaki
Publication date: 01-12-2009
Publisher: BioMed Central
Published in: Critical Care / Issue 6/2009
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc8174

2024 ASCO Annual Meeting

Springer Medicine

Host immune response in sepsis due to ventilator-associated pneumonia: how is it different?

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

The value of a risk model for early-onset candidemia

Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies

Estimation of the diameter and cross-sectional area of the internal jugular veins in adult patients

Unraveling the role of high mobility group box protein 1 in severe trauma

Pulmonary artery catheters in acute heart failure: end of an era?

Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study